CMS will review and consider "relevant" public comments on the interim final rule on implementing Medicaid work requirements, an agency spokesperson told Inside Health Policy, adding that any ...

CMS' latest guidance on determining a medically frail exemption from Medicaid work requirements may offer administrative relief to some stakeholders, but behavioral health advocates now worry that ...

An FDA draft guidance mostly supported by pharmaceutical lobbies and patient advocacy organizations because of its potential ability to facilitate approvals of rare disease treatments is drawing ...

A bipartisan group of House lawmakers plan to introduce artificial intelligence legislation that would allow insurers to use AI to process claims but would require a human in the loop for denials of ...

The Trump administration finalized updates to its Transparency in Coverage (TIC) rule Monday (Oct. 5), requiring health plans and insurers to publish more usable pricing data and attest to its ...

The Trump administration may press pause on new agents and brokers in healthcare.gov ahead of the plan year 2027 according to a notice titled “Private Health Insurance; New Agent/Broker Registrations ...

The governors of California, Oregon, Maine, New Mexico and Virginia are asking HHS to push back its Jan. 1, 2027, start date for Medicaid work requirement and work with states to establish a ...

Senate Finance Committee members say documents show CMS plans to expand its controversial, AI-driven Medicare prior authorization model to review time-sensitive medical services like oncology care and ...

The Rare Disease Company Coalition (RDCC) is asking the Trump administration to go further in excluding treatments for rare disease patients from tariffs under Section 232 of the Trade Expansion Act ...

FDA’s staffing numbers are continuing to decrease in fiscal 2026 despite promises from HHS Secretary Robert F. Kennedy Jr. to prioritize hiring, a problem President Donald Trump’s new commissioner ...

President Donald Trump announced Friday (Sept. 18) that all 50 states, Washington D.C. and Puerto Rico have applied to take part in a model to test the use of the administration’s “most favored nation ...

CHICAGO -- A study by actuaries at the SOA Research Institute found GLP-1s and insulin are cost effective when compared with no treatment at all, with GLP-1s offering a higher cost savings, ...